Fetal gene transfer by transuterine injection of cationic liposome-DNA complexes

被引:29
作者
Gaensler, KML [1 ]
Tu, GH
Bruch, S
Liggitt, D
Lipshutz, GS
Metkus, A
Harrison, M
Heath, TD
Debs, RJ
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Calif Pacific Med Ctr, Inst Res, San Francisco, CA 94115 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[4] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[5] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
关键词
gene therapy; gene transfer; cationic liposomes; fetus; in utero;
D O I
10.1038/70729
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In utero injection of cationic liposome-DNA complexes (CLDCs) containing chloramphenicol acetyltransferase, beta-galactosidase (beta-gal), or human granulocyte colony-stimulating factor (hG-CSF) expression plasmids produced high-level gene expression in fetal rats. Tissues adjacent to the injection site exhibited the highest levels of gene expression. Chloramphenicol acetyltransferase expression persisted for at least 14 days and was reexpressed following postnatal reinjection of CLDCs. Intraperitoneal administration of the hG-CSF gene produced high serum hG-CSF levels. X-gal staining demonstrated widespread beta-gal expression in multiple fetal tissues and cell types. No toxic or inflammatory responses were observed, nor was there evidence of fetal-maternal or maternal-fetal gene transfer, suggesting that CLDCs may provide a useful alternative to viral vectors for in utero gene transfer.
引用
收藏
页码:1188 / 1192
页数:5
相关论文
共 50 条
[41]   GENE-THERAPY FOR CYSTIC-FIBROSIS USING CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER - A PHASE-I TRIAL OF SAFETY AND EFFICACY IN THE NASAL AIRWAY [J].
SORSCHER, EJ ;
LOGAN, JJ ;
FRIZZELL, RA ;
LYRENE, RK ;
BEBOK, Z ;
DONG, JY ;
DUVALL, MD ;
FELGNER, PL ;
MATALON, S ;
WALKER, L ;
WIATRAK, BJ .
HUMAN GENE THERAPY, 1994, 5 (10) :1259-1277
[42]   GENE-TRANSFER INVIVO WITH DNA LIPOSOME COMPLEXES - SAFETY AND ACUTE TOXICITY IN MICE [J].
STEWART, MJ ;
PLAUTZ, GE ;
DELBUONO, L ;
YANG, ZY ;
XU, L ;
GAO, X ;
HUANG, L ;
NABEL, EG ;
NABEL, GJ .
HUMAN GENE THERAPY, 1992, 3 (03) :267-275
[43]   Improved DNA: Liposome complexes for increased systemic delivery and gene expression [J].
Templeton, NS ;
Lasic, DD ;
Frederik, PM ;
Strey, HH ;
Roberts, DD ;
Pavlakis, GN .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :647-652
[44]   SYSTEMIC GENE-THERAPY - BIODISTRIBUTION AND LONG-TERM EXPRESSION OF A TRANSGENE IN MICE [J].
THIERRY, AR ;
LUNARDIISKANDAR, Y ;
BRYANT, JL ;
RABINOVICH, P ;
GALLO, RC ;
MAHAN, LC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9742-9746
[45]   HEMATOPOIETIC STEM-CELLS IN MURINE EMBRYONIC YOLK-SAC AND PERIPHERAL-BLOOD [J].
TOLES, JF ;
CHUI, DHK ;
BELBECK, LW ;
STARR, E ;
BARKER, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7456-7459
[46]   GENE-TRANSFER AND EXPRESSION IN PROGENY AFTER INTRAVENOUS DNA INJECTION INTO PREGNANT MICE [J].
TSUKAMOTO, M ;
OCHIYA, T ;
YOSHIDA, S ;
SUGIMURA, T ;
TERADA, M .
NATURE GENETICS, 1995, 9 (03) :243-248
[47]  
VINCENT MC, 1995, HUM GENE THER, V6, P1019, DOI 10.1089/hum.1995.6.8-1019
[48]   Successful expression of human factor IX following repeat administration of an adenoviral vector in mice [J].
Walter, J ;
You, QM ;
Hagstrom, JN ;
Sands, MS ;
High, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :3056-3061
[49]   CELLULAR-IMMUNITY TO VIRAL-ANTIGENS LIMITS E1-DELETED ADENOVIRUSES FOR GENE-THERAPY [J].
YANG, YP ;
NUNES, FA ;
BERENCSI, K ;
FURTH, EE ;
GONCZOL, E ;
WILSON, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4407-4411
[50]   SYSTEMIC GENE-EXPRESSION AFTER INTRAVENOUS DNA DELIVERY INTO ADULT MICE [J].
ZHU, N ;
LIGGITT, D ;
LIU, Y ;
DEBS, R .
SCIENCE, 1993, 261 (5118) :209-211